Core Viewpoint - Baiao Chemical's stock has experienced fluctuations, with a recent decline of 2.01% and a total market capitalization of 22.394 billion yuan. The company is involved in the research, production, and sales of industrial biocides, primarily isothiazolinones, and has seen mixed financial performance in recent periods [1][2]. Group 1: Stock Performance - As of January 6, Baiao Chemical's stock price was 31.71 yuan per share, with a trading volume of 255 million yuan and a turnover rate of 1.13% [1]. - Year-to-date, the stock has decreased by 1.58%, with a slight increase of 1.47% over the last five trading days and a notable increase of 15.27% over the last 60 days [1]. Group 2: Financial Performance - For the period from January to September 2025, Baiao Chemical reported a revenue of 1.056 billion yuan, reflecting a year-on-year growth of 17.88%. However, the net profit attributable to shareholders decreased by 50.83% to 125 million yuan [2]. - Cumulatively, since its A-share listing, Baiao Chemical has distributed a total of 1.224 billion yuan in dividends, with 722 million yuan distributed over the last three years [3]. Group 3: Shareholder Information - As of September 30, 2025, the number of Baiao Chemical's shareholders increased by 12.51% to 24,000, while the average number of circulating shares per person decreased by 11.12% to 29,483 shares [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 4.0587 million shares, an increase of 1.6304 million shares from the previous period, while the Southern CSI 1000 ETF reduced its holdings by 45,500 shares [3].

12月29日，百傲化学盘中上涨2.02%，截至10:03，报31.88元/股，成交1.38亿元，换手率0.62%，总市值 225.14亿元。 资金流向方面，主力资金净流入1237.04万元，特大单买入1611.80万元，占比11.69%，卖出705.65万 元，占比5.12%；大单买入3347.98万元，占比24.28%，卖出3017.08万元，占比21.88%。 百傲化学今年以来股价涨106.16%，近5个交易日涨3.41%，近20日涨0.03%，近60日涨28.08%。 分红方面，百傲化学A股上市后累计派现12.24亿元。近三年，累计派现7.22亿元。 机构持仓方面，截止2025年9月30日，百傲化学十大流通股东中，香港中央结算有限公司位居第六大流 通股东，持股405.87万股，相比上期增加163.04万股。南方中证1000ETF（512100）位居第七大流通股 东，持股322.56万股，相比上期减少4.55万股。华夏中证1000ETF（159845）位居第九大流通股东，持 股191.93万股，为新进股东。 责任编辑：小浪快报 今年以来百傲化学已经4次登上龙虎榜，最近一次登上龙虎榜为12月15日，当日龙虎 ...

12月26日，百傲化学盘中上涨2.03%，截至10:31，报30.66元/股，成交1.04亿元，换手率0.48%，总市值 216.53亿元。 资金流向方面，主力资金净流入1101.86万元，特大单买入1357.34万元，占比13.07%，卖出598.18万 元，占比5.76%；大单买入3100.53万元，占比29.85%，卖出2757.82万元，占比26.55%。 百傲化学今年以来股价涨98.27%，近5个交易日跌0.10%，近20日跌9.16%，近60日涨20.05%。 今年以来百傲化学已经4次登上龙虎榜，最近一次登上龙虎榜为12月15日，当日龙虎榜净买入-1351.48 万元；买入总计1.09亿元 ，占总成交额比14.10%；卖出总计1.23亿元 ，占总成交额比15.85%。 资料显示，大连百傲化学股份有限公司位于辽宁省大连市中山区港东街12号一方金融广场A座11楼，成 立日期2003年9月22日，上市日期2017年2月6日，公司主营业务涉及异噻唑啉酮类工业杀菌剂的研发、 生产和销售。主营业务收入构成为：工业杀菌剂54.95%，半导体44.36%，关键零部件及耗材0.23%，销 售副产品0.23%，其他0 ...

Group 1 - The core point of the news is that Baiao Chemical's stock price has dropped by 5%, currently trading at 32.28 CNY per share, with a total market capitalization of 22.797 billion CNY [1] - Baiao Chemical, established on September 22, 2003, and listed on February 6, 2017, specializes in the research, production, and sales of isothiazolinone industrial biocides [1] - The company's main business revenue composition includes industrial biocides (54.95%), semiconductors (44.36%), key components and consumables (0.23%), by-products (0.23%), and others (0.22%) [1] Group 2 - Huatai Baoxing Fund holds a significant position in Baiao Chemical, with its fund "Huatai Baoxing Industrial Upgrade Mixed Initiation A" (021792) owning 70,000 shares, accounting for 5.03% of the fund's net value [2] - The fund has experienced a floating loss of approximately 119,000 CNY today [2] - The fund was established on September 24, 2024, with a current scale of 19.6441 million CNY and has achieved a year-to-date return of 47.73% [2]

11月19日，百傲化学跌5%，截至发稿，报32.28元/股，成交4.41亿元，换手率1.89%，总市值227.97亿 元。 资料显示，大连百傲化学股份有限公司位于辽宁省大连市中山区港东街12号一方金融广场A座11楼，成 立日期2003年9月22日，上市日期2017年2月6日，公司主营业务涉及异噻唑啉酮类工业杀菌剂的研发、 生产和销售。主营业务收入构成为：工业杀菌剂54.95%，半导体44.36%，关键零部件及耗材0.23%，销 售副产品0.23%，其他0.22%。 从基金十大重仓股角度 数据显示，中银证券旗下1只基金重仓百傲化学。中银证券优选行业龙头混合A（009640）三季度增持 10.67万股，持有股数35.5万股，占基金净值比例为9.58%，位居第三大重仓股。根据测算，今日浮亏损 失约60.35万元。 中银证券优选行业龙头混合A（009640）成立日期2020年9月1日，最新规模6201.85万。今年以来收益 56.34%，同类排名499/8138；近一年收益53.56%，同类排名674/8055；成立以来亏损33.43%。 中银证券优选行业龙头混合A（009640）基金经理为宋方云。 截至发稿，宋方云 ...

Core Viewpoint - Baiao Chemical's stock has shown significant growth this year, with a year-to-date increase of 119.15%, indicating strong market performance and investor interest [1][2]. Financial Performance - For the period from January to September 2025, Baiao Chemical achieved a revenue of 1.056 billion yuan, representing a year-on-year growth of 17.88% [2]. - The net profit attributable to shareholders for the same period was 125 million yuan, which reflects a substantial decrease of 50.83% compared to the previous year [2]. Stock Market Activity - As of November 12, Baiao Chemical's stock price was 33.89 yuan per share, with a trading volume of 327 million yuan and a turnover rate of 1.40% [1]. - The company has appeared on the stock market's "Dragon and Tiger List" three times this year, with the most recent occurrence on August 28 [1]. Shareholder Information - As of September 30, the number of shareholders for Baiao Chemical increased by 12.51% to 24,000, while the average number of circulating shares per person decreased by 11.12% to 29,483 shares [2]. - The top ten circulating shareholders include significant institutional investors, with Hong Kong Central Clearing Limited holding 4.0587 million shares, an increase of 1.6304 million shares from the previous period [3]. Business Overview - Baiao Chemical, established on September 22, 2003, and listed on February 6, 2017, specializes in the research, production, and sales of isothiazolinone-based industrial biocides [1]. - The company's revenue composition includes 54.95% from industrial biocides and 44.36% from semiconductors, with minor contributions from other segments [1].

Core Viewpoint - Baiao Chemical's stock has shown significant growth this year, with a year-to-date increase of 108.74%, indicating strong market performance and investor interest [1][2]. Financial Performance - For the period from January to September 2025, Baiao Chemical achieved a revenue of 1.056 billion yuan, representing a year-on-year growth of 17.88% [2]. - The net profit attributable to shareholders for the same period was 125 million yuan, which reflects a substantial decrease of 50.83% compared to the previous year [2]. Stock Market Activity - As of November 11, Baiao Chemical's stock price was 32.28 yuan per share, with a market capitalization of 22.797 billion yuan [1]. - The stock has seen a trading volume of 1.16 billion yuan and a turnover rate of 0.51% on the same day [1]. - The stock has appeared on the "Dragon and Tiger List" three times this year, with the most recent appearance on August 28 [1]. Shareholder Information - As of September 30, 2025, the number of shareholders increased by 12.51% to 24,000, while the average circulating shares per person decreased by 11.12% to 29,483 shares [2][3]. - The top ten circulating shareholders include significant institutional investors, with Hong Kong Central Clearing Limited holding 4.0587 million shares, an increase of 1.6304 million shares from the previous period [3]. Dividend Distribution - Since its A-share listing, Baiao Chemical has distributed a total of 1.224 billion yuan in dividends, with 722 million yuan distributed over the past three years [3].

Group 1 - The core point of the news is that Baiao Chemical's stock price has dropped by 5.19%, currently trading at 31.26 CNY per share, with a total market capitalization of 22.077 billion CNY [1] - Baiao Chemical, established on September 22, 2003, and listed on February 6, 2017, specializes in the research, production, and sales of isothiazolinone industrial biocides [1] - The company's main business revenue composition includes industrial biocides at 54.95%, semiconductors at 44.36%, and other minor segments [1] Group 2 - According to data, a fund under Bank of China Securities has heavily invested in Baiao Chemical, with the fund increasing its holdings by 106,700 shares in the third quarter, bringing the total to 355,000 shares, which constitutes 9.58% of the fund's net value [2] - The fund, named Bank of China Securities Preferred Industry Leaders Mixed A (009640), has a total scale of 62.0185 million CNY and has achieved a year-to-date return of 60.17% [2] - The fund manager, Song Fangyun, has been in position for 2 years and 317 days, with the best fund return during this period being 22.23% and the worst being -39.29% [3]

Group 1 - The core point of the news is that Baiao Chemical's stock price has dropped by 5.19%, currently trading at 31.26 CNY per share, with a total market capitalization of 22.077 billion CNY [1] - Baiao Chemical, established on September 22, 2003, and listed on February 6, 2017, specializes in the research, production, and sales of isothiazolinone-based industrial biocides [1] - The company's main business revenue composition includes industrial biocides at 54.95%, semiconductors at 44.36%, key components and consumables at 0.23%, by-products at 0.23%, and others at 0.22% [1] Group 2 - From the perspective of fund holdings, Huatai Baoxing Fund has a significant position in Baiao Chemical, with its Huatai Baoxing Industrial Upgrade Mixed Fund A (021792) holding 70,000 shares, accounting for 5.03% of the fund's net value [2] - The fund has reported a floating loss of approximately 119,700 CNY as of the current date [2] - The Huatai Baoxing Industrial Upgrade Mixed Fund A was established on September 24, 2024, with a current scale of 19.6441 million CNY and has achieved a year-to-date return of 53.88% [2]

Group 1 - The core point of the news is that Baiao Chemical's stock price increased by 5.41% to 27.88 CNY per share, with a trading volume of 535 million CNY and a turnover rate of 2.85%, resulting in a total market capitalization of 19.69 billion CNY [1] - Baiao Chemical, established on September 22, 2003, and listed on February 6, 2017, specializes in the research, production, and sales of isothiazolinone industrial biocides [1] - The company's main business revenue composition includes industrial biocides at 54.95%, semiconductors at 44.36%, key components and consumables at 0.23%, sales of by-products at 0.23%, and others at 0.22% [1] Group 2 - Among Baiao Chemical's top ten circulating shareholders, a fund under Southern Fund, the Southern CSI 1000 ETF (512100), entered the top ten in the second quarter, holding 3.2711 million shares, which accounts for 0.46% of the circulating shares [2] - The Southern CSI 1000 ETF (512100) was established on September 29, 2016, with a latest scale of 64.953 billion CNY, achieving a year-to-date return of 29.81% and a one-year return of 34.98% [2] - The fund manager of Southern CSI 1000 ETF is Cui Lei, who has been in the position for 6 years and 339 days, with a total fund asset size of 94.976 billion CNY and a best fund return of 164.18% during the tenure [3]